Literature DB >> 23279622

Measurement of factor VIII pharmacokinetics in routine clinical practice.

S Björkman1, P Collins.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23279622     DOI： 10.1111/jth.12055

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  12 in total

1.  Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data.

Authors:  João A Abrantes; Siv Jönsson; Mats O Karlsson; Elisabet I Nielsen
Journal:  Br J Clin Pharmacol       Date:  2019-04-29       Impact factor: 4.335

Review 2.  Using pharmacokinetics to individualize hemophilia therapy.

Authors:  Alfonso Iorio
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 3.  Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings.

Authors:  Iftekhar Mahmood
Journal:  Clin Pharmacokinet       Date:  2014-04       Impact factor: 6.447

Review 4.  Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia.

Authors:  Massimo Morfini; Stefano Gherardini
Journal:  Ther Adv Hematol       Date:  2018-06-05

Review 5.  Haemophilia.

Authors:  Erik Berntorp; Kathelijn Fischer; Daniel P Hart; Maria Elisa Mancuso; David Stephensen; Amy D Shapiro; Victor Blanchette
Journal:  Nat Rev Dis Primers       Date:  2021-06-24       Impact factor: 52.329

6.  Relationship between factor VIII activity, bleeds and individual characteristics in severe hemophilia A patients.

Authors:  João A Abrantes; Alexander Solms; Dirk Garmann; Elisabet I Nielsen; Siv Jönsson; Mats O Karlsson
Journal:  Haematologica       Date:  2019-08-01       Impact factor: 9.941

7.  Pharmacokinetic-tailored approach to hemophilia prophylaxis: Medical decision making and outcomes.

Authors:  Stacy E Croteau; Allison P Wheeler; Osman Khan; Kristina M Haley; Alexandra J Borst; Susan Lattimore; Cindy H T Yeung; Alfonso Iorio
Journal:  Res Pract Thromb Haemost       Date:  2020-02-06

8.  Bayesian Forecasting Utilizing Bleeding Information to Support Dose Individualization of Factor VIII.

Authors:  João A Abrantes; Alexander Solms; Dirk Garmann; Elisabet I Nielsen; Siv Jönsson; Mats O Karlsson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-10-30

9.  Focusing in on use of pharmacokinetic profiles in routine hemophilia care.

Authors:  Stacy E Croteau; Michael U Callaghan; Joanna Davis; Amy L Dunn; Michael Guerrera; Osman Khan; Ellis J Neufeld; Leslie J Raffini; Michael Recht; Michael Wang; Alfonso Iorio
Journal:  Res Pract Thromb Haemost       Date:  2018-05-27

Review 10.  Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations.

Authors:  Alfonso Iorio; Andrea N Edginton; Victor Blanchette; Jan Blatny; Ana Boban; Marjon Cnossen; Peter Collins; Stacy E Croteau; Katheljin Fischer; Daniel P Hart; Shinya Ito; Joan Korth-Bradley; Stefan Lethagen; David Lillicrap; Mike Makris; Ron Mathôt; Massimo Morfini; Ellis J Neufeld; Jeffrey Spears
Journal:  Res Pract Thromb Haemost       Date:  2018-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.